✦ LIBER ✦

The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: Data from a randomized, Phase III study

✍ Scribed by Susanna Esposito; Paola Marchisio; Valentina Montinaro; Sonia Bianchini; Gerrit Jan Weverling; Elena Pariani; Antonella Amendola; Valentina Fabiano; Valentina Pivetti; Alessandro Zanetti; Gian Vincenzo Zuccotti

Book ID: 118503353
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 282 KB
Volume: 30
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.09.069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized clinical trial assessing im

A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months

✍ Susanna Esposito; Paola Marchisio; Filippo Ansaldi; Sonia Bianchini; Michela Pac 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 178 KB

The immunogenicity and safety of a single 0.5&#xa0;mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: Data from a randomized, Phase III study

The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: Data from a randomized, Phase III study